HeartSciences

HeartSciences is a publicly traded AI-enabled medical technology and healthcare IT company focused on improving the diagnostic value of electrocardiography for earlier detection of heart disease. The company is developing two main product lines: the MyoVista Insights cloud-native ECG management and AI-analysis platform, and the MyoVista wavECG on-device ECG system. Its technology is designed to work either through existing installed ECG hardware or through proprietary upgraded ECG devices, with applications including detection of reduced ejection fraction, aortic stenosis, and left ventricular diastolic dysfunction. HeartSciences positions MyoVista Insights as a device-agnostic ECG management stack and marketplace for both its own and third-party AI-ECG algorithms. The company is based in Southlake, Texas and trades on Nasdaq under HSCS.